Related Experiment Video
Updated: Sep 23, 2026

Model of Ischemia and Reperfusion Injury in Rabbits
Published on: November 3, 2023
TxA2-mediated myocardial ischemia as a consequence of an acute lung inflammatory reaction in the rabbit
V Evangelista1, G Dell'Elba, A Celardo
1G. Bizzozero Laboratory of Blood and Vascular Cell Interactions, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. evangeli@negrisud.it
Abstract:
Epidemiological studies link acute infection of the respiratory tract to a transient increased risk of acute myocardial infarction. The underlying mechanisms remain unknown. We hypothesized that vasoactive mediators produced by inflammatory cells in the lungs and drained in the coronary circulation may trigger acute myocardial ischemia. To test this hypothesis we used an experimental model in the rabbit. Injection of the bacterial-derived peptide N-formyl-Met-Leu-Phe (or N-formyl-Methionyl-Leucyl-Phenylalanine)(fMLP) in the jugular vein induced massive recruitment of both polymorphonuclear leukocytes (PMN) and platelets in the microcirculation of the lungs, accompanied by rapid and marked increase of leukotriene B4, cysteinyl leukotrienes and thromboxane (Tx) A2 in the aortic blood. In all animals, fMLP evoked ischemic electrocardiographic changes: within the first minute of infusion a profound depression of the ST segment and inversion of the T wave were observed. Mean aortic pressure and heart rate fell to 64.0 +/- 6.9 and 83.5 +/- 3.1% of the basal levels at 3 and 10 min, respectively. All these alterations were transient. Aspirin, prevented electrocardiographic ischemic changes, reverted bradycardia and hypotension but did not significantly modify either PMN or platelet recruitment nor leukotriene synthesis. Ridogrel, a Tx-synthase and receptor inhibitor, prevented ECG alterations and bradycardia, but did not prevent and even worsened hypotension; it blocked platelet, but not PMN, sequestration. Pretreatment of animals with intravenous high dose of aspirin prevented ridogrel-dependent hypotension and platelet inhibition, suggesting that PGI2 contributes to the effects of Tx-synthase and receptor inhibitor. In hypercholesterolemic rabbits, ECG alterations persisted longer than in normal controls. In summary, our results indicate that acute activation of PMN and platelets in the lungs provokes transient myocardial ischemia, in normal animals that is exacerbated in hypercholesterolemic rabbits. TxA2 appears to be the major mediator of this phenomenon. Moreover the data suggest that a balance between TxA2 and PGI2 plays a pivotal role in platelet activation and recruitment in our model.
Insights
Respiratory infections transiently increase heart attack risk. Lung inflammation activates immune cells and platelets, releasing mediators like thromboxane A2 (TxA2), causing myocardial ischemia, especially in hypercholesterolemic rabbits.
Area of Science:
- Cardiovascular Research
- Inflammation and Immunology
- Pulmonary Medicine
Background:
- Acute respiratory tract infections are linked to a temporary rise in acute myocardial infarction (heart attack) risk.
- The precise biological mechanisms underlying this association remain unclear.
- Vasoactive mediators released from lung inflammatory cells may enter coronary circulation, triggering myocardial ischemia.
Purpose of the Study:
- To investigate the hypothesis that inflammatory mediators from the lungs can induce acute myocardial ischemia.
- To elucidate the role of specific inflammatory cells and mediators in this process.
- To examine the influence of hypercholesterolemia on this phenomenon.
Main Methods:
- An experimental rabbit model was utilized.
- The bacterial peptide N-formyl-Met-Leu-Phe (fMLP) was injected intravenously to induce lung inflammation and mediator release.
- Electrocardiographic (ECG) changes, hemodynamic parameters, and inflammatory cell/platelet recruitment were monitored.
- The effects of aspirin and ridogrel (a thromboxane inhibitor) were assessed.
Main Results:
- fMLP injection caused rapid polymorphonuclear leukocyte (PMN) and platelet recruitment in lung microcirculation.
- Significant increases in leukotrienes and thromboxane A2 (TxA2) were observed in aortic blood.
- fMLP induced transient ischemic ECG changes, bradycardia, and hypotension.
- Aspirin prevented ECG changes and hemodynamic alterations but not cell recruitment.
- Ridogrel prevented ECG changes and bradycardia, but worsened hypotension and only partially inhibited platelet sequestration.
- In hypercholesterolemic rabbits, ECG alterations were more prolonged.
Conclusions:
- Acute activation of PMN and platelets in the lungs can precipitate transient myocardial ischemia.
- Thromboxane A2 (TxA2) is identified as a primary mediator of this ischemic event.
- Hypercholesterolemia exacerbates the duration of myocardial ischemia.
- A balance between TxA2 and prostacyclin (PGI2) appears crucial for platelet activation and recruitment in this model.

